Qi H, Gao H, Li M, Sun T, Gu X, Wei L, Zhi M, Li Z, Fu D, Liu Y, Wei Z, Dou Y, Feng Q.
Nat Commun. 2025 Mar 7;16(1):2305. doi: 10.1038/s41467-025-57530-1.
PMID:40055343
Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression.
Chang Y, Huang Z, Hou F, Liu Y, Wang L, Wang Z, Sun Y, Pan Z, Tan Y, Ding L, Gao H, Yang R, Bi Y.
J Exp Clin Cancer Res. 2023 Jan 10;42(1):13. doi: 10.1186/s13046-022-02572-2.
PMID:36627634
Parvimonas micra, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes.
Bergsten E, Mestivier D, Donnadieu F, Pedron T, Barau C, Meda LT, Mettouchi A, Lemichez E, Gorgette O, Chamaillard M, Vaysse A, Volant S, Doukani A, Sansonetti PJ, Sobhani I, Nigro G.
Gut Microbes. 2023 Dec;15(2):2265138. doi: 10.1080/19490976.2023.2265138. Epub 2023 Oct 16.
PMID:37842920
Parvimonas micra infection enhances proliferation, wound healing, and inflammation of a colorectal cancer cell line.